WallStSmart

American International Group Inc (AIG)vsFold Holdings, Inc. Class A Common Stock (FLD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

American International Group Inc generates 83599% more annual revenue ($26.61B vs $31.79M). AIG leads profitability with a 11.6% profit margin vs -218.9%. AIG earns a higher WallStSmart Score of 60/100 (C).

AIG

Buy

60

out of 100

Grade: C

Growth: 2.0Profit: 5.0Value: 7.0Quality: 7.0
Piotroski: 5/9Altman Z: 0.88

FLD

Buy

53

out of 100

Grade: C-

Growth: 8.0Profit: 4.0Value: 5.0Quality: 4.3
Piotroski: 5/9Altman Z: -4.00

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIG4 strengths · Avg: 8.8/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.868/10

Growing faster than its price suggests

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

FLD4 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Return on EquityProfitability
278.6%10/10

Every $100 of equity generates 279 in profit

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

EPS GrowthGrowth
1622.0%10/10

Earnings expanding 1622.0% YoY

Areas to Watch

AIG4 concerns · Avg: 2.3/10
Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

Revenue GrowthGrowth
-7.2%2/10

Revenue declined 7.2%

EPS GrowthGrowth
-5.6%2/10

Earnings declined 5.6%

Altman Z-ScoreHealth
0.882/10

Distress zone — elevated risk

FLD4 concerns · Avg: 2.0/10
Market CapQuality
$77.24M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-5.03M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-4.002/10

Distress zone — elevated risk

Profit MarginProfitability
-218.9%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AIG

The strongest argument for AIG centers on Price/Book, Debt/Equity, PEG Ratio. PEG of 0.86 suggests the stock is reasonably priced for its growth.

Bull Case : FLD

The strongest argument for FLD centers on Price/Book, Return on Equity, Revenue Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bear Case : AIG

The primary concerns for AIG are Return on Equity, Revenue Growth, EPS Growth.

Bear Case : FLD

The primary concerns for FLD are Market Cap, Free Cash Flow, Altman Z-Score.

Key Dynamics to Monitor

AIG profiles as a declining stock while FLD is a hypergrowth play — different risk/reward profiles.

AIG carries more volatility with a beta of 0.60 — expect wider price swings.

FLD is growing revenue faster at 41.2% — sustainability is the question.

AIG generates stronger free cash flow (636M), providing more financial flexibility.

Bottom Line

AIG scores higher overall (60/100 vs 53/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American International Group Inc

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

American International Group, Inc., also known as AIG, is an American multinational finance and insurance corporation with operations in more than 80 countries and jurisdictions. The company operates through three core businesses: General Insurance, Life & Retirement, and a standalone technology-enabled subsidiary.

Fold Holdings, Inc. Class A Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Fold Holdings, Inc. (FLD) is a dynamic biotechnology firm focused on developing revolutionary therapies for severe genetic and rare diseases through cutting-edge research. The company boasts a promising product pipeline underpinned by proprietary technologies and strategic partnerships that enhance its competitive positioning in the market. Committed to scientific excellence and patient-centered solutions, Fold is poised for sustainable growth and value creation, making it a compelling investment opportunity in the evolving healthcare landscape.

Visit Website →

Want to dig deeper into these stocks?